News – Page 1098 – Endpoints News

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

8 years ago

Shire plots an ADHD public spinoff as CEO Ornskov completes a top-to-bottom overhaul

8 years ago

FDA experts turn thumbs down on J&J’s troubled rheumatoid arthritis drug sirukumab

8 years ago

After a $200M financing, Highland Therapeutics falls silent on ADHD drug’s fate as PDUFA sails by

8 years ago

Ocular cuts staff in wake of FDA slapdown; Biogen recruits Pfizer vet; X4 inks discovery deal with Yale

8 years ago

Clementia keeps the biotech IPO party going with $120M play on an upsized offering

8 years ago

Running out of cash and kicked out of its HQ by the landlord, PixarBio hunkers down and slashes staff

8 years ago

Spark Therapeutics offers a glimpse of efficacy in first two hemophilia A gene therapy patients

8 years ago

Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib

8 years ago

Amplyx grabs $67M to fund a pivotal drive to the FDA with an anti-fungal aimed at a lethal threat

8 years ago

Updated: Celgene, Agios win a landmark FDA OK for new AML drug Idhifa

8 years ago

Despite blockbuster boasts for R&D work, pressure increases on Pfizer to do a megadeal

8 years ago

Lexicon grabs co-promo option on diabetes drug; Shkreli jury enters second day of deliberations

8 years ago

Indivior gets a speedy review for opioid addiction drug as FDA vows to fight a crisis

8 years ago

Looking for an oncology reboot, Sanofi, Regeneron shoot for a fast and flashy FDA OK of a promising new PD-1

8 years ago

After taking a PhIII thrashing, AstraZeneca comes out swinging with breakthrough titles, new cancer hires

8 years ago

Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo

8 years ago

A fast-moving entry in the gene editing race is speeding to the clinic, fueled by an $83.5M round

8 years ago

FDA slams J&J’s blockbuster contender sirukumab on ‘important safety risks’

8 years ago

AstraZeneca bags a ‘breakthrough’ for bruised checkpoint drug Imfinzi; Inotek CSO takes the helm at Flex

8 years ago

InVivo Therapeutics shares tank after a third patient death in lead study

8 years ago

Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race

8 years ago

Bristol-Myers, Clovis leap into PhIII combo studies in a PD-1/PARP play as rivals circle

8 years ago

Loxo beefs up its genetics-based cancer drug pipeline with an unusual $40M deal

8 years ago

First page Previous page 1095 1096 109710981099 1100 1101 Next page Last page